SHINKAI; Hisashi
Patent Applications and Registrations
Patent applications and USPTO patent grants for SHINKAI; Hisashi.The latest application filed is for "fluorene compound and pharmaceutical use thereof".
Company Profile
3.22.28
- SHINKAI; Hisashi - Takatsuki JP
- Shinkai; Hisashi - Osaka JP
- Shinkai; Hisashi - Takatsuki-shi JP
- Shinkai; Hisashi - Takaatsuki JP
- Shinkai, Hisashi - Takaatsuki-shi JP
- Shinkai; Hisashi - Kawasaka JP
- Shinkai; Hisashi - Kawasaki JP
Patent Activity
| Patent | Date |
|---|---|
| Fluorene Compound And Pharmaceutical Use Thereof App 20200308109 - Motomura; Takahisa ; et al. | 2020-10-01 |
| 4-oxoquinoline Compound And Use Thereof As Pharmaceutical Agent App 20200101061 - Satoh; Motohide ; et al. | 2020-04-02 |
| Fluorene Compound And Pharmaceutical Use Thereof App 20190177271 - MOTOMURA; Takahisa ; et al. | 2019-06-13 |
| Fluorene Compound And Pharmaceutical Use Thereof App 20150329491 - MOTOMURA; Takahisa ; et al. | 2015-11-19 |
| 4-oxoquinoline Compound And Use Thereof As Pharmaceutical Agent App 20150174117 - SATOH; Motohide ; et al. | 2015-06-25 |
| CETP activity inhibitors Grant 9,000,045 - Shinkai , et al. April 7, 2 | 2015-04-07 |
| Fluorene compound and pharmaceutical use thereof Grant 8,871,934 - Motomura , et al. October 28, 2 | 2014-10-28 |
| Fluorene Compound And Pharmaceutical Use Thereof App 20130274240 - Motomura; Takahisa ; et al. | 2013-10-17 |
| 4-oxoquinoline Compound And Use Thereof As Hiv Integrase Inhibitor App 20130172344 - SATOH; Motohide ; et al. | 2013-07-04 |
| Cetp Activity Inhibitors App 20130053417 - Shinkai; Hisashi ; et al. | 2013-02-28 |
| Fluorene compound and pharmaceutical use thereof Grant 8,343,994 - Motomura , et al. January 1, 2 | 2013-01-01 |
| 4-oxoquinoline compound and use thereof as HIV integrase inhibitor Grant 8,232,401 - Satoh , et al. July 31, 2 | 2012-07-31 |
| Quinolinyl and benzothiazolyl modulators Grant 7,960,408 - McGee , et al. June 14, 2 | 2011-06-14 |
| 6-(heterocyclyl-substituted benzyl)-4-oxoquinoline compound and use thereof as HIV integrase inhibitor Grant 7,872,004 - Satoh , et al. January 18, 2 | 2011-01-18 |
| Dibenzylamine compounds and pharmaceutical use thereof Grant 7,807,701 - Maeda , et al. October 5, 2 | 2010-10-05 |
| Fluorene Compound and Pharmaceutical Use Thereof App 20100240634 - Motomura; Takahisa ; et al. | 2010-09-23 |
| Cetp Activity Inhibitors App 20100197736 - SHINKAI; Hisashi ; et al. | 2010-08-05 |
| Quinolizinone compound and use thereof as HIV integrase inhibitor Grant 7,745,459 - Satoh , et al. June 29, 2 | 2010-06-29 |
| Quinolinyl and benzothiazolyl modulators Grant 7,601,841 - McGee , et al. October 13, 2 | 2009-10-13 |
| Quinolinyl And Benzothiazolyl Modulators App 20090221635 - McGee; Lawrence R. ; et al. | 2009-09-03 |
| CETP activity inhibitors Grant 7,579,379 - Shinkai , et al. August 25, 2 | 2009-08-25 |
| 4-oxoquinoline compound and use thereof as HIV integrase inhibitor Grant 7,531,554 - Satoh , et al. May 12, 2 | 2009-05-12 |
| 6- (Heterocyclyl-substituted Benzyl) -4-Oxoquinoline Compound and Use Thereof as HIV Integrase Inhibitor App 20080207618 - SATOH; Motohide ; et al. | 2008-08-28 |
| Dibenzylamine Compounds and Pharmaceutical Use Thereof App 20080146620 - Maeda; Kimiya ; et al. | 2008-06-19 |
| Dibenzylamine compound and medicinal use thereof Grant 7,332,514 - Maeda , et al. February 19, 2 | 2008-02-19 |
| CETP Activity Inhibitors App 20080027109 - Shinkai; Hisashi ; et al. | 2008-01-31 |
| CETP activity inhibitors Grant 7,271,196 - Shinkai , et al. September 18, 2 | 2007-09-18 |
| 4-oxoquinoline compound and use thereof as pharmaceutical agent Grant 7,176,220 - Satoh , et al. February 13, 2 | 2007-02-13 |
| 4-Oxoquinoline compound and use thereof as HIV integrase inhibitor App 20060217413 - Satoh; Motohide ; et al. | 2006-09-28 |
| Quinolizinone compound and use thereof as HIV integrase inhibitor App 20060084665 - Satoh; Motohide ; et al. | 2006-04-20 |
| Amide derivatives and nociceptin antagonists App 20060030565 - Shinkai; Hisashi ; et al. | 2006-02-09 |
| Novel 4-oxoquinoline compound and use thereof as HIV integrase inhibitor App 20060019906 - Satoh; Motohide ; et al. | 2006-01-26 |
| 4-Oxoquinoline compounds and utilization thereof as hiv integrase inhibitors App 20050239819 - Satoh, Motohide ; et al. | 2005-10-27 |
| Amide derivatives and nociceptin antagonists Grant 6,903,094 - Shinkai , et al. June 7, 2 | 2005-06-07 |
| Dibenzylamine compound and medicinal use thereof App 20050059810 - Maeda, Kimiya ; et al. | 2005-03-17 |
| CETP activity inhibitors App 20040229957 - Shinkai, Hisashi ; et al. | 2004-11-18 |
| Quinolinyl and benzothiazolyl modulators App 20040176409 - McGee, Lawrence R. ; et al. | 2004-09-09 |
| CETP activity inhibitor Grant 6,753,346 - Shinkai , et al. June 22, 2 | 2004-06-22 |
| Quinolinyl and benzothiazolyl modulators App 20030171399 - McGee, Lawrence R. ; et al. | 2003-09-11 |
| Quinolinyl and benzothiazolyl modulators Grant 6,583,157 - McGee , et al. June 24, 2 | 2003-06-24 |
| CETP activity inhibitor App 20030092708 - Shinkai, Hisashi ; et al. | 2003-05-15 |
| Amide derivatives and nociceptin antagonists App 20030055087 - Shinkai, Hisashi ; et al. | 2003-03-20 |
| Quinolinyl And Benzothiazolyl Modulators App 20020169185 - McGee, Lawrence R. ; et al. | 2002-11-14 |
| CETP activity inhibitors Grant 6,426,365 - Shinkai , et al. July 30, 2 | 2002-07-30 |
| Propionic acid derivatives and applications thereof Grant 6,204,277 - Shinkai , et al. March 20, 2 | 2001-03-20 |
| Hypoglycemic agent Grant RE34,878 - Toyoshima , et al. March 14, 1 | 1995-03-14 |
| Hypoglycemic agent Grant 4,816,484 - Toyoshima , et al. March 28, 1 | 1989-03-28 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 